5 Best Biotech Stocks To Buy Under $20

4. Iovance Biotherapeutics Inc (NASDAQ:IOVA)

Price: $15.70

Nr of Hedge Funds Shareholders: 34

Iovance Biotherapeutics Inc (NASDAQ:IOVA) is focused on developing tumor infiltrating lymphocyte therapy for treatment of cancer. The company’s approach aims to harness the human immune system to recognize and attack cancer cells. At the end of December, the FDA placed a clinical hold on Iovance Biotherapeutics Inc (NASDAQ:IOVA) trial for its cell therapy in lung cancer patients after a patient death, but earlier this month the company announced that the hold had been lifted. The same therapy is also trialed for melanoma and Iovance Biotherapeutics assured that the clinical hold will not have an impact on this or other studies.

Among the top shareholders of Iovance Biotherapeutics Inc (NASDAQ:IOVA) are MHR Fund Management, led by Mark Rachesky, and Joseph Edelman’s Perceptive Advisors, which own 20 million shares and 11.98 million shares, according to their last 13F filings.